Gaudium IVF And Women Health Limited
Bookbuilding IPO · NSE, BSE
- Price band
- ₹75 - ₹79
- Lot size
- 189 shares
- Issue amount
- ₹165 cr
- Total subscription
- 7.27×
- Opens
- 20 Feb 2026
- Closes
- 24 Feb 2026
- Allotment
- 25 Feb 2026
- Listing
- 27 Feb 2026
Offer at a glance
Issue overview
- Issue size
- 2,08,86,200 shares
- Face value
- ₹5 per share
- Minimum investment
- ₹14,175
- Fresh issue
- ₹90 cr
- Offer for sale
- ₹75 cr
- Registrar
- Bigshare Services Private Limited
- Listing exchange
- NSE, BSE
- Maximum investment
- ₹14,931
- Issue type
- Bookbuilding IPO
- Shares before issue
- 6,13,94,384
- Shares after issue
- 7,27,86,884
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 189 | ₹14,931 |
| sHNI | 14 | 2,646 | ₹2,09,034 |
| bHNI | 67 | 12,663 | ₹10,00,377 |
Share reservation
Subscription & GMP
Subscription by category
Reported 24 Feb 2026
GMP history
Day-wise demand
Application-wise demand
| Category | Reserved applications | Applied applications |
|---|---|---|
| RETAIL | 38,678 | 2,40,713 |
| HNIs(10L +) | 789 | 1,984 |
| HNIs (2-10L) | 395 | 6,296 |
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 33 | 53.61 |
| RETAIL | 57.75 | 438.79 |
| HNIs 2+ | 8.25 | 137.98 |
| HNIs 10+ | 16.5 | 209.79 |
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Key performance indicators
| Metric | Sep-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
| EPS | 2.04 | 3.12 | 1.68 | 2.2 |
| ROE | 21.25 | 41.31 | 38.23 | 59.51 |
| ROCE | 21.03 | 39.37 | 38.74 | 54.4 |
| RONW | 0 | 0 | 0 | 0 |
| PRE IPO(PE) | 0 | 25.36 | 0 | 0 |
| POST IPO(PE) | 22.99 | 0 | 0 | 0 |
Values and labels as reported in the issue data.
Peer comparison
| Company | P/E(X) | CMP* (₹) | Face value (₹) | NAV/Share (₹) | RONW(%) | EPS (Basic) (₹) |
|---|---|---|---|---|---|---|
| Progyny Inc | 41.56 | 2099.98 | 0.0001 | 394.20 | 12.90 | 50.52 |
| Inspire IVF Public Company Limited | 11.43 | 1.99 | 0.05 | 4.34 | 3.97 | 3.97 |
| Gaudium IVF and Women Health Limited | 25.36 | 79.00 | 5.00 | 7.54 | 41.71 | 3.12 |
Company information
Company profile
Founded in March 2015, Gaudium IVF and Women Health Limited specializes in In Vitro Fertilization (IVF) and women’s healthcare services across India, operating through a hub-and-spoke model with seven hubs and twenty-eight spokes. The company collaborates with Infertility Experts to promote awareness of Assisted Reproductive Technology (ART) and IVF treatments. Serving patients from countries like Canada, the UK, the USA, Kenya, South Africa, and Oman, Gaudium has centres in key cities such as Delhi, Mumbai, Ludhiana, Srinagar, Patna, and Bangalore. It offers advanced fertility treatments including IVF, ICSI, IUI, ovulation induction, and male infertility solutions, along with specialized care for PCOD/PCOS, endometriosis, and high-risk pregnancies.
Strengths
- Patient-Centric Care: Focuses on personalized fertility and women’s healthcare solutions.
- Experienced Medical Team: Skilled fertility specialists drive strong clinical outcomes.
- Advanced Lab Infrastructure: Equipped with next-gen INTEGRA Ti technology for high-precision procedures.
Risk factors
- Healthcare & Legal Risk: Fertility treatments face strict medical, regulatory, and reputational scrutiny.
- Dependence on Medical Professionals: Difficulty in attracting or retaining specialists may affect performance.
- Brand Reputation Risk: Negative publicity or allegations could impact patient trust and business growth.
Promoters
Dr. Manika Khanna
Dr. Peeyush Khanna
Vishad Khanna
Registrar & documents
Lead manager
Sarthi Capital Advisors Private Limited
Registrar & contacts
Bigshare Services Private Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
B1/51, Janak Puri, B-1, New Delhi, New Delhi, 110058
011-4885 8585
[email protected]Company website ↗Understanding GAUDIUMIVF IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.